Skip To Main Content

Inspiration and Innovation

Get inspired and stay on the cutting edge of innovation with these resources.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content
Lenalidomide Refractory Patients

Lenalidomide Refractory Patients

Multiple Myeloma: Minimal Residual Disease

Multiple Myeloma: Minimal Residual Disease

Multiple Myeloma: Chromosome 1q+ cytogenetic abnormalities

Multiple Myeloma: Chromosome 1q+ cytogenetic abnormalities

Gaucher disease awareness month video

Gaucher disease awareness month video

What can biologic treatment do for patients with CRS with nasal polyps?

What can biologic treatment do for patients with CRS with nasal polyps?

Rethink Your Nasal Polyps. Type 2 Inflammation A Nasal Polyp Mystery

Rethink Your Nasal Polyps. Type 2 Inflammation A Nasal Polyp Mystery

Pneumology Meets Oto-Rhino-Laryngology: A Discussion of Type 2 Inflammation in Airway Diseases

Pneumology Meets Oto-Rhino-Laryngology: A Discussion of Type 2 Inflammation in Airway Diseases

Hear From An Expert On Would You Consider A Biologic For A Surgery-Naïve Patient With Crs With Nasal Polyps?

Hear From An Expert On Would You Consider A Biologic For A Surgery-Naïve Patient With Crs With Nasal Polyps?

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Type 2 Inflammation Is The Underlying Cause Of Crswnp In 80% Of Patients.

Hear From An Expert On What Have You Learned From Your Experience With Biologics?

Hear From An Expert On What Have You Learned From Your Experience With Biologics?

Hear From An Expert On What Does The Future Of Treatment Look Like For Crs With Nasal Polyps?

Hear From An Expert On What Does The Future Of Treatment Look Like For Crs With Nasal Polyps?

Hear From An Expert On What Does Dupixent Bring To Your Practice?

Hear From An Expert On What Does Dupixent Bring To Your Practice?